The influence of sphingosine-1-phosphate receptor antagonists on gentamicin-induced hair cell loss of the rat cochlea
- PMID: 24397911
- DOI: 10.1016/j.neulet.2013.12.063
The influence of sphingosine-1-phosphate receptor antagonists on gentamicin-induced hair cell loss of the rat cochlea
Abstract
Sphingosine-1-phosphate (S1P) is a sphingolipid metabolite that regulates various critical biological processes, such as cell proliferation, survival, migration, and angiogenesis. The action of S1P is exerted by its binding to 5 specific G protein-coupled S1P receptors (S1PR), S1PR1-S1PR5. Aminoglycoside antibiotics including gentamicin induce cochlear hair cell loss and sensorineural hearing loss. Apoptotic cell death is considered to play a key role in this type of cochlear injury. S1P acts as a cochlear protectant against gentamicin ototoxicity. In the present study, expression of S1PRs in the cochlea was examined. In addition, the effects of S1PR antagonists on gentamicin ototoxicity were investigated using tissue culture techniques. Cochleas were dissected from Sprague-Dawley rats on postnatal days 3-5. Basal turn organ of Corti explants were exposed to 35 μM gentamicin for 48 h with or without S1PR antagonists. S1PR(1-3) were expressed in the organ of Corti and spiral ganglion. The S1PR2 antagonist increased gentamicin-induced hair cell loss, while the S1PR1 and S1PR3 antagonists did not affect gentamicin ototoxicity. These results indicate the possibility that S1P act as a cochlear protectant against gentamicin ototoxicity via activation of S1PR2.
Keywords: Cochlea hair cell loss; Gentamicin ototoxicity; S1P receptor (S1PR); Sphingosine-1-phosphate (S1P).
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea.Neurosci Lett. 2010 Nov 12;485(1):1-5. doi: 10.1016/j.neulet.2010.08.014. Epub 2010 Aug 13. Neurosci Lett. 2010. PMID: 20709153
-
Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway.Hear Res. 2010 Mar;261(1-2):67-74. doi: 10.1016/j.heares.2010.01.004. Epub 2010 Jan 13. Hear Res. 2010. PMID: 20074632
-
Effects of neuroactive steroids on cochlear hair cell death induced by gentamicin.Steroids. 2011 Dec 11;76(13):1443-50. doi: 10.1016/j.steroids.2011.07.014. Epub 2011 Aug 12. Steroids. 2011. PMID: 21856322
-
Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.Curr Mol Pharmacol. 2018;11(4):279-284. doi: 10.2174/1874467211666180516101111. Curr Mol Pharmacol. 2018. PMID: 29766830 Review.
-
[Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].Laryngorhinootologie. 2004 May;83(5):317-23. doi: 10.1055/s-2004-814280. Laryngorhinootologie. 2004. PMID: 15143449 Review. German.
Cited by
-
Targeting Phospholipid Metabolism as an Effective Hearing Protection Strategy.Neurosci Bull. 2025 Jun 28. doi: 10.1007/s12264-025-01433-0. Online ahead of print. Neurosci Bull. 2025. PMID: 40580390
-
Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.Neurotox Res. 2016 Jan;29(1):35-46. doi: 10.1007/s12640-015-9563-7. Neurotox Res. 2016. PMID: 26472207
-
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.Front Pharmacol. 2016 Jun 21;7:167. doi: 10.3389/fphar.2016.00167. eCollection 2016. Front Pharmacol. 2016. PMID: 27445808 Free PMC article. Review.
-
Bile Acid Application in Cell-Targeting for Molecular Receptors in Relation to Hearing: A Comprehensive Review.Curr Drug Targets. 2024;25(3):158-170. doi: 10.2174/0113894501278292231223035733. Curr Drug Targets. 2024. PMID: 38192136 Review.
-
Genetic Polymorphisms Associated with Hearing Threshold Shift in Subjects during First Encounter with Occupational Impulse Noise.PLoS One. 2015 Jun 29;10(6):e0130827. doi: 10.1371/journal.pone.0130827. eCollection 2015. PLoS One. 2015. PMID: 26121033 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical